Literature DB >> 23979110

Prognostic indicator for the resection of liver metastasis of colorectal cancer.

Ryosuke Amano1, Nobuya Yamada, Bunzo Nakata, Kenjiro Kimura, Masakazu Yashiro, Masaichi Ohira, Kosei Hirakawa.   

Abstract

PURPOSE: We investigated the predictive indicator for a good prognosis of surgical resection for liver metastasis of colorectal cancer.
METHOD: Between 1990 and 2009 at our institute, 117 patients underwent 132 hepatic resections for liver metastasis of colorectal cancer. The clinical, pathological, and outcome parameters affecting their prognoses were analyzed. The extent of the liver metastases was subdivided according to the Japanese Classification of Colorectal Carcinoma (JCCRC), and the patients were classified into different grades based on the JCCRC classification and the status of the nodal involvement of the primary tumor. RESULT: The median survival time (MST) of the 117 patients was 58 months, and the actuarial survival rates at 1, 3, and 5 years were 92.3, 60.0, and 46.1 %, respectively. A multivariate analysis revealed that the JCCRC Grade classification was an independent prognostic indicator (Grade A vs. B vs. C: MST, 72 vs. 41 vs. 23 months; 5-year survival, 59.0 vs. 38.6 vs. 0 %: p < 0.0001).
CONCLUSION: Our findings indicate that the JCCRC Grade classification for liver metastasis of colorectal cancer is a significant prognostic indicator and may be useful for making decisions regarding the treatment of liver metastasis.

Entities:  

Mesh:

Year:  2013        PMID: 23979110     DOI: 10.1007/s00595-013-0699-x

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  30 in total

1.  Late results justify resection for multiple hepatic metastases from colorectal cancer.

Authors:  M Rees; G Plant; S Bygrave
Journal:  Br J Surg       Date:  1997-08       Impact factor: 6.939

2.  The natural history of primary and secondary malignant tumors of the liver. I. The prognosis for patients with hepatic metastases from colonic and rectal carcinoma by laparotomy.

Authors:  S Bengmark; L Hafström
Journal:  Cancer       Date:  1969-01       Impact factor: 6.860

3.  The prognostic nutritional index can be a prognostic indicator in colorectal carcinoma.

Authors:  Tadahiro Nozoe; Mayuko Kohno; Tomohiro Iguchi; Emiko Mori; Takashi Maeda; Akito Matsukuma; Takahiro Ezaki
Journal:  Surg Today       Date:  2011-12-03       Impact factor: 2.549

4.  Liver resection for colorectal metastases.

Authors:  Y Fong; A M Cohen; J G Fortner; W E Enker; A D Turnbull; D G Coit; A M Marrero; M Prasad; L H Blumgart; M F Brennan
Journal:  J Clin Oncol       Date:  1997-03       Impact factor: 44.544

5.  Long-term survival following resection of colorectal hepatic metastases. Association Française de Chirurgie.

Authors:  D Jaeck; P Bachellier; M Guiguet; K Boudjema; J C Vaillant; P Balladur; B Nordlinger
Journal:  Br J Surg       Date:  1997-07       Impact factor: 6.939

6.  Extended resections of liver metastases from colorectal cancer.

Authors:  S Jonas; A Thelen; C Benckert; A Spinelli; S Sammain; U Neumann; B Rudolph; P Neuhaus
Journal:  World J Surg       Date:  2007-03       Impact factor: 3.352

7.  Is hepatic resection justified after chemotherapy in patients with colorectal liver metastases and lymph node involvement?

Authors:  René Adam; Robbert J de Haas; Dennis A Wicherts; Thomas A Aloia; Valérie Delvart; Daniel Azoulay; Henri Bismuth; Denis Castaing
Journal:  J Clin Oncol       Date:  2008-08-01       Impact factor: 44.544

Review 8.  Treatment of colorectal cancer: hepatic metastasis.

Authors:  Y Fong; N Kemeny; P Paty; L H Blumgart; A M Cohen
Journal:  Semin Surg Oncol       Date:  1996 Jul-Aug

9.  Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study.

Authors:  Leonard B Saltz; Stephen Clarke; Eduardo Díaz-Rubio; Werner Scheithauer; Arie Figer; Ralph Wong; Sheryl Koski; Mikhail Lichinitser; Tsai-Shen Yang; Fernando Rivera; Felix Couture; Florin Sirzén; Jim Cassidy
Journal:  J Clin Oncol       Date:  2008-04-20       Impact factor: 44.544

10.  Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer.

Authors:  Herbert Hurwitz; Louis Fehrenbacher; William Novotny; Thomas Cartwright; John Hainsworth; William Heim; Jordan Berlin; Ari Baron; Susan Griffing; Eric Holmgren; Napoleone Ferrara; Gwen Fyfe; Beth Rogers; Robert Ross; Fairooz Kabbinavar
Journal:  N Engl J Med       Date:  2004-06-03       Impact factor: 91.245

View more
  11 in total

1.  Is intraoperative ultrasound still useful for the detection of colorectal cancer liver metastases?

Authors:  Guillaume Hoch; Valérie Croise-Laurent; Adeline Germain; Laurent Brunaud; Laurent Bresler; Ahmet Ayav
Journal:  HPB (Oxford)       Date:  2015-02-28       Impact factor: 3.647

2.  The clinical relevance of the Fong and the Nordlinger scores in the era of effective neoadjuvant chemotherapy for colorectal liver metastasis.

Authors:  Teresa Schreckenbach; Patrizia Malkomes; Wolf O Bechstein; Guido Woeste; Andreas A Schnitzbauer; Frank Ulrich
Journal:  Surg Today       Date:  2015-01-07       Impact factor: 2.549

3.  Selective transarterial radioembolisation of unresectable liver-dominant colorectal cancer refractory to chemotherapy.

Authors:  Rita Golfieri; Cristina Mosconi; Emanuela Giampalma; Alberta Cappelli; Maria Cristina Galaverni; Cinzia Pettinato; Matteo Renzulli; Fabio Monari; Renzo Mazzarotto; Carmine Pinto; Bruna Angelelli
Journal:  Radiol Med       Date:  2015-02-13       Impact factor: 3.469

4.  Metastasis from a primary hepatic angiosarcoma to the colon: A case report and literature review.

Authors:  Yukako Mokutani; Taishi Hata; Yuichiro Miyake; Hideki Kuroda; Hidekazu Takahashi; Naotsugu Haraguchi; Junichi Nishimura; Tsunekazu Mizushima; Hirofumi Yamamoto; Yuichiro Doki; Masaki Mori
Journal:  Oncol Lett       Date:  2017-02-21       Impact factor: 2.967

5.  Analysis of prognostic factors after resection of solitary liver metastasis in colorectal cancer: a 22-year bicentre study.

Authors:  Sara Acciuffi; Frank Meyer; Astrid Bauschke; Utz Settmacher; Hans Lippert; Roland Croner; Annelore Altendorf-Hofmann
Journal:  J Cancer Res Clin Oncol       Date:  2018-01-16       Impact factor: 4.553

6.  Prognostic Factors in Terms of the Number of Metastatic Nodules in Patients With Colorectal Cancer Liver Metastases.

Authors:  Ki Ung Jang; Chan Wook Kim; Ki-Hun Kim; Seok-Byung Lim; Chang Sik Yu; Tae Won Kim; Pyo Nyun Kim; Jong Hoon Kim; Jin Cheon Kim
Journal:  Ann Coloproctol       Date:  2016-06-30

7.  Down-Regulation of microRNA-132 is Associated with Poor Prognosis of Colorectal Cancer.

Authors:  Yukako Mokutani; Mamoru Uemura; Koji Munakata; Daisuke Okuzaki; Naotsugu Haraguchi; Hidekazu Takahashi; Junichi Nishimura; Taishi Hata; Kohei Murata; Ichiro Takemasa; Tsunekazu Mizushima; Yuichiro Doki; Masaki Mori; Hirofumi Yamamoto
Journal:  Ann Surg Oncol       Date:  2016-02-11       Impact factor: 5.344

8.  Transcriptome analysis in primary colorectal cancer tissues from patients with and without liver metastases using next-generation sequencing.

Authors:  Sen Wang; Chuan Zhang; Zhiyuan Zhang; Wenwei Qian; Ye Sun; Bing Ji; Yue Zhang; Chunyan Zhu; Dongjian Ji; Qingyuan Wang; Yueming Sun
Journal:  Cancer Med       Date:  2017-07-26       Impact factor: 4.452

9.  Exosomal microRNA in serum is a novel biomarker of recurrence in human colorectal cancer.

Authors:  T Matsumura; K Sugimachi; H Iinuma; Y Takahashi; J Kurashige; G Sawada; M Ueda; R Uchi; H Ueo; Y Takano; Y Shinden; H Eguchi; H Yamamoto; Y Doki; M Mori; T Ochiya; K Mimori
Journal:  Br J Cancer       Date:  2015-06-09       Impact factor: 7.640

10.  SP1-induced lncRNA-ZFAS1 contributes to colorectal cancer progression via the miR-150-5p/VEGFA axis.

Authors:  Xiaoxiang Chen; Kaixuan Zeng; Mu Xu; Xiuxiu Hu; Xiangxiang Liu; Tao Xu; Bangshun He; Yuqin Pan; Huiling Sun; Shukui Wang
Journal:  Cell Death Dis       Date:  2018-09-24       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.